PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
47.77%
Revenue growth above 1.5x VMC's 30.32%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
103.38%
Gross profit growth similar to VMC's 94.23%. Walter Schloss would assume both firms track common industry trends.
6432.14%
EBIT growth above 1.5x VMC's 161.78%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
6432.14%
Operating income growth above 1.5x VMC's 161.78%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1018.10%
Net income growth above 1.5x VMC's 199.90%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1081.25%
EPS growth above 1.5x VMC's 198.72%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1075.00%
Diluted EPS growth above 1.5x VMC's 200.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.33%
Share reduction while VMC is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.66%
Reduced diluted shares while VMC is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-36.31%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
309.39%
OCF growth above 1.5x VMC's 15.97%. David Dodd would confirm a clear edge in underlying cash generation.
171.54%
Positive FCF growth while VMC is negative. John Neff would see a strong competitive edge in net cash generation.
24.81%
10Y revenue/share CAGR under 50% of VMC's 152.21%. Michael Burry would suspect a lasting competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
-16.11%
Negative 3Y CAGR while VMC stands at 48.45%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
733.85%
10Y OCF/share CAGR 1.25-1.5x VMC's 614.70%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
No Data
No Data available this quarter, please select a different quarter.
8.99%
Positive 3Y OCF/share CAGR while VMC is negative. John Neff might see a big short-term edge in operational efficiency.
3001.72%
Net income/share CAGR above 1.5x VMC's 563.71% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
No Data
No Data available this quarter, please select a different quarter.
112.60%
3Y net income/share CAGR above 1.5x VMC's 58.18%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
140.48%
10Y equity/share CAGR above 1.5x VMC's 86.79%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
No Data
No Data available this quarter, please select a different quarter.
22.38%
3Y equity/share CAGR similar to VMC's 22.81%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
114.32%
Below 50% of VMC's 820.46%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
No Data
No Data available this quarter, please select a different quarter.
-25.28%
Negative near-term dividend growth while VMC invests at 24.20%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
22.82%
AR growth well above VMC's 19.76%. Michael Burry fears inflated revenue or higher default risk in the near future.
-2.27%
Inventory is declining while VMC stands at 0.48%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.82%
Asset growth above 1.5x VMC's 2.20%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.77%
1.25-1.5x VMC's 2.84%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
3.16%
Debt growth far above VMC's 2.43%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
9.01%
SG&A growth well above VMC's 2.85%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.